London Cartilage Clinic
Explore expert articles on cartilage care, regenerative treatments, and practical recovery advice from our specialist team.
ChondroFiller is a non-surgical, ultrasound-guided collagen injection — so returning to exercise after the procedure is usually straightforward. Most people stay active within comfortable limits and ease back into higher-impact activity over the following weeks. It is not surgery and does not cure or reverse arthritis; benefits vary.
Arthrosamid, a minimally invasive polyacrylamide hydrogel injection, offers a promising treatment for knee osteoarthritis (OA). By cushioning the knee joint, it helps reduce pain and improve mobility, enabling patients to rediscover joy in hobbies like photography walks, light hiking, and golf. Supported by research demonstrating efficacy and safety for at least two years, Arthrosamid enhances quality of life and emotional well-being. Expert care from specialists such as Professor Paul Lee ensures personalized treatment and guidance. Ideal outcomes combine Arthrosamid with ongoing activity and physiotherapy. This approach provides renewed freedom and comfort for those affected by knee OA, helping them return to their cherished activities safely and confidently.
Discover the vital role of knee cartilage in joint health and the challenges in repairing this specialized tissue due to its limited blood supply. Explore current treatments like microfracture surgery and autologous chondrocyte implantation alongside groundbreaking advances such as scaffolds, stem cell therapy, 3D bioprinting, gene therapy, and growth factors. Learn how these innovations promise improved, long-lasting solutions for knee cartilage injuries, potentially restoring pain-free mobility and transforming future care. Stay informed with the latest research on overcoming biological hurdles and enhancing cartilage regeneration to maintain healthy, functional knees.
Septic arthritis is a serious hidden cause of intense, persistent knee pain caused by bacterial infection. It triggers an immune response that damages joint cartilage and bone, leading to lasting pain and stiffness if untreated. Key symptoms include sudden knee pain, swelling, warmth, and fever. Diagnosis combines joint fluid analysis, blood tests, and imaging, as symptoms can mimic other joint issues. Treatment involves prolonged antibiotics and often surgical drainage to clear infection and reduce inflammation. Early detection and intervention are critical to prevent irreversible joint damage. Ongoing research is exploring therapies targeting inflammation to improve recovery and preserve knee function. Awareness and prompt medical care offer the best chance to protect knee health from the lasting impacts of septic arthritis.
ChondroFiller is a non-surgical, intra-articular collagen injection used to support joint preservation in osteoarthritis and joint wear. It is not right for everyone: people with very advanced arthritis or severe joint degeneration, and some with health conditions that impair healing, may be better suited to other options. Careful, individual assessment matters most. As a collagen-based injection it has biological potential, but it is not surgery and does not cure or reverse arthritis. This article reviews the main considerations for deciding who may, and may not, be suitable.
This article compares two non-surgical injection options for joint wear: the ChondroFiller injection and hyaluronic acid. ChondroFiller is a CE-marked, cell-free type I collagen scaffold that may add a protective, cushioning layer over worn joint surfaces, supporting joint preservation. Hyaluronic acid mainly improves lubrication for shorter-term symptom relief. Neither is a cure or reversal of arthritis; individual responses vary.
